GA2LEN NoE calls for more focus on allergies in FP7

The Network of Excellence (NoE) GA2LEN is urging policy makers to support the European Parliament's proposal to include allergic diseases in the health priorities of the Seventh Framework Programme (FP7).

While allergies are mentioned among the food research priorities in the European Commission's proposal, members of GA2LEN would like to see the wider allergy problem a top priority for health research. Only 8% of allergies in Europe are related to food.

"The absence of the wider allergy problem as a top concern in health research agenda threatens to compromise overall progress in the understanding of this complex condition," says the Network in a statement.

Allergies are a global problem, although the presentation and cause of the reactions vary. Researchers believe that the many different aspects of the condition, as well as its triggers, must be addressed if we are to gain a comprehensive understanding of allergic diseases as a whole.

Allergies can be fatal. According to the World Health Organization (WHO), asthma kills someone in Europe every hour. And the problem is becoming more widespread -one child in three is now allergic to something, and by 2015, half of all Europeans may be suffering from one or more allergic condition.

For sufferers, allergies can have a major impact of daily life. Children with allergic diseases miss days at school and must sometimes abstain from sport and other recreational activities, while breathing and skin problems dent the confidence of children and adults.

GA2LEN also highlights the financial costs of allergies, which estimates suggest amount to €100 billion per year.

The GA2LEN network brings together 26 allergy research centres around Europe with the aim of advancing diagnosis, prevention and treatment of allergic diseases. In recent months, a European database of comparable, longitudinal epidemiological studies, known has cohorts, has been completed. This should help scientists to conduct a more reliable analysis of the multiple genetic and environmental factors causing allergies.

For further information on GA2LEN, please visit:
http://www.ga2len.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...